XR Securities’s Elevance Health ELV Stock Holding History

XR Securities’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,497	Closed	-$2.07M	–	408
2023 Q1	$2.07M	Sell	4,497 -2,991	-40%	-$1.42M	0.05%	109
2022 Q4	$3.84M	Buy	7,488 +6,500	+658%	+$3.3M	0.38%	43
2022 Q3	$449K	Buy	+988	New	+$473K	0.24%	82
2022 Q1	–	Sell	-620	Closed	-$287K	–	396
2021 Q4	$287K	Buy	+620	New	+$261K	0.03%	167
2021 Q2	–	Sell	-686	Closed	-$246K	–	457
2021 Q1	$246K	Buy	+686	New	+$221K	0.01%	175
2020 Q1	–	Sell	-14,566	Closed	-$4.4M	–	230
2019 Q4	$4.4M	Buy	14,566 +5,781	+66%	+$1.59M	0.58%	11
2019 Q3	$2.11M	Buy	+8,785	New	+$2.41M	0.29%	16
2018 Q3	–	Sell	-2,144	Closed	-$557K	–	411
2018 Q2	$510K	Buy	+2,144	New	+$496K	0.18%	58

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

XR Securities's ELV Position: Q2 2023 in Review

XR Securities sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 4,497 shares — an estimated $2.07M sold.

XR Securities first reported a position in ELV in Q2 2018 and held it in 8 quarters. The position peaked at $4.4M in Q4 2019. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

XR Securities reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
XR Securities sold 4,497 Elevance Health shares in Q2 2023, an estimated $2.07M.
XR Securities first reported a position in Elevance Health in Q2 2018 and held it in 8 quarters.
XR Securities's Elevance Health position peaked at $4.4M in Q4 2019.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.